Barclays Downgrades Sonova (OTCMKTS:SONVY) to Hold

Barclays cut shares of Sonova (OTCMKTS:SONVY) from a strong-buy rating to a hold rating in a report published on Wednesday,Zacks.com reports.

SONVY has been the subject of a number of other research reports. The Goldman Sachs Group raised shares of Sonova to a “strong sell” rating in a research report on Tuesday, October 22nd. UBS Group raised shares of Sonova to a “hold” rating in a report on Tuesday, August 13th.

Sonova Stock Performance

OTCMKTS:SONVY opened at $69.75 on Wednesday. Sonova has a one year low of $54.18 and a one year high of $77.56. The business’s 50-day simple moving average is $72.44 and its 200 day simple moving average is $66.75. The company has a current ratio of 1.45, a quick ratio of 1.07 and a debt-to-equity ratio of 0.63.

About Sonova

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.